Status:

WITHDRAWN

Transversus Abdominis Plane (TAP) Block After Kidney Transplantation

Lead Sponsor:

University of California, San Francisco

Conditions:

Transplantation, Kidney

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Postoperative pain is a major problem in patients who either donate a kidney or undergo kidney transplantation. This pain is commonly treated with opioids, which can cause several side effects, rangin...

Eligibility Criteria

Inclusion

  • Age \> 18 years, English speaking, receiving a kidney transplant or donating a kidney as part of standard clinical care

Exclusion

  • Allergy to local anesthetics or opioids, coagulopathy or dementia. Patients with known history of IV drug abuse and with very high preoperative opioid requirements (defined as \> 120 mg oxycodone/ day, use of methadone or fentanyl patches) will also be excluded from this study.
  • Coagulopathy will be assessed by the patient's history and physical. Should there be concerns regarding "easy bleeding" or "easy bruising", further workup of the patient's coagulation will be ordered (PT, PTT, INR). Since we perform the TAP block after 3-4 hours of kidney surgery, any patient with coagulopathy will most likely have been canceled prior to surgery. Therefore, we would deem any patient, who was eligible for kidney surgery, eligible for a TAP block at the end of the surgical procedure.

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01496729

Start Date

January 1 2012

End Date

January 1 2013

Last Update

October 10 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCSF Medical Center at Parnassus

San Francisco, California, United States, 94143